Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Toulemonde

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Nephron|January 1, 1985
Continuous arteriovenous hemofiltration with low-molecular-weight heparinB Hory, A Cachoux, F Toulemonde
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|November 1, 1983
[Current data on fibrinolytic agents used in clinical medicine]E G Vairel, J Choay, F Toulemonde
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|November 1, 1983
[Heparins and thrombosis]E G Vairel, J Choay, F Toulemonde
Seminars in Thrombosis and Hemostasis|July 1, 1985
Oral administration of low molecular weight heparin fractions in rabbitsC Doutremépuich, F Toulemonde, J C Lormeau
Thrombosis and Haemostasis|April 7, 1987
Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancyF Forestier, F Daffos, M Rainaut, et al.
Bulletin De L'Academie Nationale De Medecine|April 1, 1986
[Revival and adverse effects of heparin therapy: low molecular weight heparins; thrombogenic thrombopenias]A Larcan, M C Laprevote-Heully, F Toulemonde
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1987
[Absence of transplacental passage of Fraxiparin (low molecular weight heparin) during the 3d trimester of pregnancy]F Forestier, F Daffos, M Rainaut, et al.
Thrombosis Research|September 15, 1986
Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (CY 216) in rabbitsC Doutremepuich, F Toulemonde, F Bousquet, et al.
Thrombosis Research|October 15, 1992
Effects of aprotinin on heparin activities and heparin neutralization with protamineF Azougagh Oualane, F Toulemonde, F Doutremepuich, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1983
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]J Roussi, L Houbouyan, D Rosenthal, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Nephron|January 1, 1985
Continuous arteriovenous hemofiltration with low-molecular-weight heparinB Hory, A Cachoux, F Toulemonde
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|November 1, 1983
[Current data on fibrinolytic agents used in clinical medicine]E G Vairel, J Choay, F Toulemonde
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|November 1, 1983
[Heparins and thrombosis]E G Vairel, J Choay, F Toulemonde
Seminars in Thrombosis and Hemostasis|July 1, 1985
Oral administration of low molecular weight heparin fractions in rabbitsC Doutremépuich, F Toulemonde, J C Lormeau
Thrombosis and Haemostasis|April 7, 1987
Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancyF Forestier, F Daffos, M Rainaut, et al.
Bulletin De L'Academie Nationale De Medecine|April 1, 1986
[Revival and adverse effects of heparin therapy: low molecular weight heparins; thrombogenic thrombopenias]A Larcan, M C Laprevote-Heully, F Toulemonde
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1987
[Absence of transplacental passage of Fraxiparin (low molecular weight heparin) during the 3d trimester of pregnancy]F Forestier, F Daffos, M Rainaut, et al.
Thrombosis Research|September 15, 1986
Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (CY 216) in rabbitsC Doutremepuich, F Toulemonde, F Bousquet, et al.
Thrombosis Research|October 15, 1992
Effects of aprotinin on heparin activities and heparin neutralization with protamineF Azougagh Oualane, F Toulemonde, F Doutremepuich, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1983
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]J Roussi, L Houbouyan, D Rosenthal, et al.
Pageof 7